Where does Confluent Medical Technologies, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Confluent Medical Technologies, Inc. ranks #34,830 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Confluent Medical Technologies, Inc. hold?

Confluent Medical Technologies, Inc. holds 7 US utility patents granted between 2017 and 2024, spanning 10 technology areas.

What is Confluent Medical Technologies, Inc.'s Innovation Score?

Confluent Medical Technologies, Inc. has an Innovation Score of 36.3 out of 100 (top 47% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Confluent Medical Technologies, Inc.'s patent grant rate increasing or decreasing?

Confluent Medical Technologies, Inc.'s recent grant velocity is +33% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Confluent Medical Technologies, Inc.'s patents?

Confluent Medical Technologies, Inc.'s patents average 18.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Confluent Medical Technologies, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Confluent Medical Technologies, Inc.

Q: What technology areas does Confluent Medical Technologies, Inc. focus on?

Confluent Medical Technologies, Inc.'s top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 5 patents, ranking #1,311 of 3,490 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 7 granted patents across 10 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Confluent ranks #34,830 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 10 technology areas.

#34,830
of 49,997 US assignees by volume: Top 47%
by Innovation Score (36.3/100): 18.9
avg claims per patent: +33%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R34830 · US Corporation #34,830 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #34,830/49,997
PHOTO-FINISH Comprehensive…
CPC-FOCUS A61M · 10 areas
INNOV-THIN 36.3/100
CLAIMS-RICH 18.9 claims/avg
TYPE-USCORP US Corporation
VEL-UP +33% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Comprehensive Biomarker Center GmbH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Confluent’s 36.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (20%) Velocity 6.7 pts (18%) Breadth 11.2 pts (31%) Claim depth 11.3 pts (31%)

Qualcomm Incorporated · highest

85
Confluent Medical · this assignee

36
3D Lighting… · lowest

7

What this shows Confluent's Innovation Score is 36.3/100 (top 47% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Confluent?

Each dot is one of Confluent’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Confluent’s own 18.9 claims/patent is ABOVE the 15.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Confluent vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Confluent's grants concentrate

Confluent Medical Technologies, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 71.4% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2017 (2 grants) versus a trough of 1 in 2018. By volume, Confluent sits between Comprehensive Biomarker Center GmbH and Consolidated Engineering Company, Inc..

Confluent's three-year grant acceleration

Confluent Medical Technologies, Inc. shows 2 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Comprehensive Bio…

7
Compressor Contro…

7
Contipi Medical

7
Concurrent Comput…

7
Confluera

7
Conscience Inform…

7
Consider Provisio…

7
Consolidated Engi…

7
Confluent Medical ◀

7

What this shows Confluent holds 7 patents at rank #34,870, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Confluent

By rank, the assignees closest to #34,870 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Confluent's primary technology class.

Confluent's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 47% higher than 53% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Confluent Medical Technologies, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	2	28.6%
2018	1	14.3%
2020	1	14.3%
2021	1	14.3%
2022	1	14.3%
2024	1	14.3%

Which technologies does Confluent Medical Technologies, Inc. patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 5

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 3

Y10T - Technical Subjects Covered BY Former US Classification 2

A61B - DIAGNOSIS; SURGERY; Identification 1

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 1

C22F - Changing THE Physical Structure OF Non-ferrous Metals AND Non-ferrous Alloys 1

C21D - Modifying THE Physical Structure OF Ferrous METALS; General Devices FOR Heat Treatment OF Ferrous OR Non-ferrous Metals OR ALLOYS; Making Metal Malleable, e.g. BY Decarburisation OR Tempering 1

C22C - Alloys 1

B32B - Layered Products, i.e. Products Built-up OF Strata OF Flat OR Non-flat, e.g. Cellular OR Honeycomb, Form 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Confluent Medical Technologies, Inc.'s patent record in context - here's where to go next.

Confluent Medical Technologies, Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 71.4% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #34,830 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Confluent Medical Technologies, Inc. against Comprehensive Biomarker Center GmbH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.